Annual EBITDA
-$64.56 M
-$7.69 M-13.52%
30 June 2022
Summary:
Applied Genetic Technologies annual earnings before interest, taxes, depreciation & amortization is currently -$64.56 million, with the most recent change of -$7.69 million (-13.52%) on 30 June 2022. During the last 3 years, it has fallen by -$7.69 million (-13.52%).AGTC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$17.31 M
-$42.00 K-0.24%
30 September 2022
Summary:
Applied Genetic Technologies quarterly earnings before interest, taxes, depreciation & amortization is currently -$17.31 million, with the most recent change of -$42.00 thousand (-0.24%) on 30 September 2022.AGTC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$65.81 M
-$1.25 M-1.94%
30 September 2022
Summary:
Applied Genetic Technologies TTM earnings before interest, taxes, depreciation & amortization is currently -$65.81 million, with the most recent change of -$1.25 million (-1.94%) on 30 September 2022.AGTC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -13.5% | -7.8% | -12.9% |
| 5 y5 years | -1998.3% | -54.2% | -328.0% |
AGTC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -2394.4% | -252.8% | -688.5% |
Applied Genetic Technologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$17.31 M(+0.2%) | -$65.81 M(+1.9%) |
| June 2022 | -$64.56 M(+13.5%) | -$17.26 M(+30.8%) | -$64.56 M(+6.3%) |
| Mar 2022 | - | -$13.20 M(-26.9%) | -$60.74 M(-1.5%) |
| Dec 2021 | - | -$18.05 M(+12.4%) | -$61.67 M(+5.8%) |
| Sept 2021 | - | -$16.05 M(+19.5%) | -$58.31 M(+2.5%) |
| June 2021 | -$56.88 M(+28.1%) | -$13.44 M(-4.8%) | -$56.88 M(-1.0%) |
| Mar 2021 | - | -$14.12 M(-3.9%) | -$57.48 M(+6.0%) |
| Dec 2020 | - | -$14.70 M(+0.5%) | -$54.24 M(+13.4%) |
| Sept 2020 | - | -$14.62 M(+4.1%) | -$47.81 M(+7.6%) |
| June 2020 | -$44.42 M(+1343.5%) | -$14.04 M(+29.0%) | -$44.42 M(+7.0%) |
| Mar 2020 | - | -$10.88 M(+31.7%) | -$41.50 M(+115.1%) |
| Dec 2019 | - | -$8.27 M(-26.3%) | -$19.29 M(+25.5%) |
| Sept 2019 | - | -$11.22 M(+0.9%) | -$15.38 M(+490.0%) |
| June 2019 | -$3.08 M(-85.5%) | -$11.12 M(-198.2%) | -$2.61 M(-224.5%) |
| Mar 2019 | - | $11.32 M(-360.1%) | $2.09 M(-112.6%) |
| Dec 2018 | - | -$4.35 M(-381.2%) | -$16.65 M(-8.7%) |
| Sept 2018 | - | $1.55 M(-124.1%) | -$18.23 M(-14.1%) |
| June 2018 | -$21.21 M(-853.7%) | -$6.42 M(-13.4%) | -$21.21 M(+22.4%) |
| Mar 2018 | - | -$7.42 M(+25.1%) | -$17.33 M(+64.7%) |
| Dec 2017 | - | -$5.93 M(+314.0%) | -$10.53 M(+376.5%) |
| Sept 2017 | - | -$1.43 M(-43.8%) | -$2.21 M(-178.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | $2.81 M(-284.9%) | -$2.55 M(+315.7%) | $2.81 M(-65.0%) |
| Mar 2017 | - | -$613.00 K(-125.7%) | $8.04 M(-24.1%) |
| Dec 2016 | - | $2.38 M(-33.6%) | $10.60 M(-5.2%) |
| Sept 2016 | - | $3.59 M(+34.0%) | $11.18 M(-834.8%) |
| June 2016 | -$1.52 M(-93.7%) | $2.68 M(+37.7%) | -$1.52 M(-87.5%) |
| Mar 2016 | - | $1.95 M(-34.5%) | -$12.13 M(-40.4%) |
| Dec 2015 | - | $2.97 M(-132.6%) | -$20.38 M(-27.1%) |
| Sept 2015 | - | -$9.12 M(+14.9%) | -$27.95 M(+15.7%) |
| June 2015 | -$24.16 M(+97.6%) | -$7.93 M(+26.0%) | -$24.16 M(+17.5%) |
| Mar 2015 | - | -$6.30 M(+36.7%) | -$20.56 M(+17.9%) |
| Dec 2014 | - | -$4.61 M(-13.4%) | -$17.44 M(+11.4%) |
| Sept 2014 | - | -$5.32 M(+22.8%) | -$15.65 M(+28.1%) |
| June 2014 | -$12.22 M(+170.8%) | -$4.33 M(+36.3%) | -$12.22 M(+32.6%) |
| Mar 2014 | - | -$3.18 M(+12.6%) | -$9.21 M(+21.9%) |
| Dec 2013 | - | -$2.82 M(+49.6%) | -$7.56 M(+28.1%) |
| Sept 2013 | - | -$1.89 M(+42.3%) | -$5.90 M(+30.7%) |
| June 2013 | -$4.51 M(+183.4%) | -$1.33 M(-13.0%) | -$4.51 M(+41.6%) |
| Mar 2013 | - | -$1.52 M(+31.0%) | -$3.19 M(+91.7%) |
| Dec 2012 | - | -$1.16 M(+133.3%) | -$1.66 M(+233.3%) |
| Sept 2012 | - | -$499.00 K | -$499.00 K |
| June 2012 | -$1.59 M | - | - |
FAQ
- What is Applied Genetic Technologies annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Applied Genetic Technologies?
What is Applied Genetic Technologies annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of AGTC is -$64.56 M
What is the all time high annual EBITDA for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual earnings before interest, taxes, depreciation & amortization is $2.81 M
What is Applied Genetic Technologies quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of AGTC is -$17.31 M
What is the all time high quarterly EBITDA for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly earnings before interest, taxes, depreciation & amortization is $11.32 M
What is Applied Genetic Technologies TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of AGTC is -$65.81 M
What is the all time high TTM EBITDA for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM earnings before interest, taxes, depreciation & amortization is $11.18 M